Back EDQM On Air – The evolution of biologicals in the European Pharmacopoeia

EDQM Strasbourg, France 25/03/2025
  • Diminuer la taille du texte
  • Augmenter la taille du texte
  • Imprimer la page
  • Imprimer en PDF
EDQM On Air – The evolution of biologicals in the European Pharmacopoeia

EDQM On Air, the podcast on public health brought to you by the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe, has just released a new episode!

Biological medicinal products – or biologicals – are a class of pharmaceutical products derived or refined from biological sources including micro-organisms, animal tissue and even human cells. These extremely powerful and versatile medicines are at the cutting-edge of pharmaceutical science and have contributed to major breakthroughs in the treatment of smallpox, diabetes and haemophilia, as well as to promising innovations such as CRISPR-Cas9 technology and CAR T-cell therapies, making us stronger in the fight against disease.

But how did we get to this point? What were the first biologicals, and how have they evolved over time? What safety concerns arise from their use? In this episode, Emmanuelle Charton from the EDQM’s European Pharmacopoeia Department walks us through the history of biologicals, from the first vaccines to the latest Nobel Prize-winning innovations.

The first six episodes of EDQM On Air are already available and others will be released regularly. Tune in for expert insight, engaging discussions and inspiring stories, and discover how the EDQM, together with its stakeholders, is safeguarding public health in more ways than you ever imagined.

See also: